CJ
Ciaffoni Joseph
Chairman & CEO
C-suiteM
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Ciaffoni Joseph, Chairman & CEO. Officer active across 4 companies, notably COLLEGIUM PHARMACEUTICAL, INC. Cumulatively, 25 disclosures have been recorded. Breakdown: 0 buy · 8 sells. Total volume traded: €2.4m. History available since 1 June 2021. The latest transaction was disclosed on 10 February 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Ciaffoni Joseph
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
1,266,903 sharesCommon StockSEC:0001443841-26-000007:0
612,549 sharesCommon StockSEC:0001443841-26-000007:1
79,976 shares0Common StockSEC:0001443841-26-000004:0
119,000 shares0Common StockSEC:0001062993-24-003166:0
4,357 shares@ US$21.341.8% of flowCommon StockSEC:0001062993-23-023100:0
27,798 shares@ US$21.3411.9% of flowCommon StockSEC:0001062993-23-022977:0
31,272 shares@ US$22.088714.0% of flowCommon StockSEC:0001062993-23-012809:0
31,271 shares@ US$21.902313.9% of flowCommon StockSEC:0001062993-23-012623:0
117,500 shares0Common StockSEC:0001062993-23-003475:0
110 shares@ US$23.000.1% of flowCommon StockSEC:0001062993-22-024500:0
147 shares@ US$23.000.1% of flowCommon StockSEC:0001062993-22-024500:1
1,804 shares@ US$23.650.9% of flowCommon StockSEC:0001062993-22-024500:2
400 shares@ US$24.190.2% of flowCommon StockSEC:0001062993-22-024500:3
1,134 shares@ US$23.010.5% of flowCommon StockSEC:0001062993-22-024355:0
76,653 shares@ US$15.9025.5% of flowCommon StockSEC:0001062993-22-023357:0
43 shares@ US$15.900.0% of flowCommon StockSEC:0001062993-22-022995:0
65 shares@ US$15.900.0% of flowCommon StockSEC:0001062993-22-022779:0
1,989 shares@ US$15.900.7% of flowCommon StockSEC:0001062993-22-022644:0
1,394 shares@ US$18.160.5% of flowCommon StockSEC:0001062993-22-016068:0
65,083 shares@ US$18.3724.0% of flowCommon StockSEC:0001062993-22-006644:0
125,000 shares0Common StockSEC:0001062993-22-004320:0
1,090 shares@ US$18.680.4% of flowCommon StockSEC:0001879789-22-000001:0
1,386 shares@ US$19.030.5% of flowCommon StockSEC:0001192482-21-000661:0
1,394 shares@ US$23.990.6% of flowCommon StockSEC:0001192482-21-000623:0
4,672 shares@ US$22.902.0% of flowCommon StockSEC:0001192482-21-000479:0
About Ciaffoni Joseph
Ciaffoni Joseph is Président-Directeur Général. Across 25 total filings, the 25 sampled filings between 2021-06-03 and 2026-06-23 show EUR 0 of purchases and EUR 2425427 of sales, with the dominant transaction nature indicated as Cession. The filings concern COLLEGIUM PHARMACEUTICAL, INC and Indivior Pharmaceuticals, Inc.